Chart of the Week: The Race to the Biomarkers Tipping Point

This week’s Chart of the Week is an interesting one.  We will most likely have a follow up after further analysis of the data from BiomarkerBase.  Basically, the chart shows the total commercial usage of a biomarker by company count since the biomarkers first...

Chart of the Week: Celgene Poised to Dominate Personalized Medicine?

In our Charts of the Week over the last several weeks we have been analyzing the use of unique biomarkers by pharmaceutical companies.  We are extending that analysis today with a look at the biomarker discovery activity of pharma companies as compared with the number...

Chart of the Week: Test Approval – Experience Counts

The most experienced test developers get their tests through the process of FDA approval or clearance 70 days faster on average and 90 days faster on median. The first quartile (bottom of box) Third quartile (top of box) The median (horizontal line within box) The...